Ellen R. Laird

2.1k total citations
33 papers, 1.3k citations indexed

About

Ellen R. Laird is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ellen R. Laird has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Ellen R. Laird's work include Melanoma and MAPK Pathways (11 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and Peptidase Inhibition and Analysis (6 papers). Ellen R. Laird is often cited by papers focused on Melanoma and MAPK Pathways (11 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and Peptidase Inhibition and Analysis (6 papers). Ellen R. Laird collaborates with scholars based in United States, Canada and Japan. Ellen R. Laird's co-authors include William L. Jorgensen, Toan B. Nguyen, Julian Tirado‐Rives, Jennifer L. Karas, Mark J. Zoller, Jay P. Morgenstern, Xiaode Lu, Jeremy Green, Marcos Hatada and Meizhen Lou and has published in prestigious journals such as Nature, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Ellen R. Laird

33 papers receiving 1.2k citations

Peers

Ellen R. Laird

ONCOL

CTM

IMMUN

A. Kuglstatter Switzerland

Yan Ling United States

Robert E. Babine United States

Pier F. Cirillo United States

Dean R. Artis United States

Juan I. Luengo United States

Alfred P. Spada United States

S. Terzyan United States

Eugene R. Hickey United States

Matthew W. D. Perry Sweden

A. Kuglstatter Switzerland

Ellen R. Laird

1.0k ×1.8

287 ×0.6

268 ×1.3

ONCOL

284 ×1.5

CTM

195 ×1.1

IMMUN

Citations per year, relative to Ellen R. Laird Ellen R. Laird (= 1×) peers A. Kuglstatter

Countries citing papers authored by Ellen R. Laird

Since Specialization

Citations

This map shows the geographic impact of Ellen R. Laird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen R. Laird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen R. Laird more than expected).

Fields of papers citing papers by Ellen R. Laird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen R. Laird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen R. Laird. The network helps show where Ellen R. Laird may publish in the future.

Co-authorship network of co-authors of Ellen R. Laird

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen R. Laird. A scholar is included among the top collaborators of Ellen R. Laird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen R. Laird. Ellen R. Laird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ren, Li, David Moreno‐Mateos, Brian R. Baer, et al.. (2024). Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 67(15). 13019–13032. 1 indexed citations

Wenglowsky, Steve, Li Ren, Jonas Grina, et al.. (2014). Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 24(8). 1923–1927. 16 indexed citations

Wenglowsky, Steve, Jonas Grina, Ellen R. Laird, et al.. (2013). Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 23(21). 5896–5899. 24 indexed citations

Bach, Peter, Jonas Boström, Laurence E. Burgess, et al.. (2013). 5-Alkyl-1,3-Oxazole Derivatives of 6-Amino-Nicotinic Acids as Alkyl Ester Bioisosteres are Antagonists of the P2Y ₁₂ Receptor. Future Medicinal Chemistry. 5(17). 2037–2056. 10 indexed citations

Ren, Li, Kateri A. Ahrendt, Jonas Grina, et al.. (2012). The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 22(10). 3387–3391. 14 indexed citations

Wenglowsky, Steve, David Moreno‐Mateos, Ellen R. Laird, et al.. (2012). Pyrazolopyridine inhibitors of B-RafV600E. Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(19). 6237–6241. 27 indexed citations

Ren, Li, Ellen R. Laird, Susan L. Gloor, et al.. (2011). Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-RafV600E kinase with favorable physicochemical and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 22(2). 1165–1168. 23 indexed citations

Wenglowsky, Steve, Kateri A. Ahrendt, Bainian Feng, et al.. (2011). Pyrazolopyridine inhibitors of B-RafV600E. Part 2: Structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 21(18). 5533–5537. 50 indexed citations

Hansen, Joshua D., Jonas Grina, M. Bruce Welch, et al.. (2010). Non-oxime pyrazole based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3488–3492. 38 indexed citations

10.

Ren, Li, Ellen R. Laird, Steve Wenglowsky, et al.. (2010). The Discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(4). 1248–1252. 22 indexed citations

11.

Ren, Li, Steve Wenglowsky, Stephen T. Schlachter, et al.. (2010). Non-oxime inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 21(4). 1243–1247. 26 indexed citations

12.

Shiozaki, Makoto, Hiroto Imai, Katsuya Maeda, et al.. (2009). Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(21). 6213–6217. 16 indexed citations

13.

Hansen, Joshua D., Jonas Grina, Brad Newhouse, et al.. (2008). Potent and selective pyrazole-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 18(16). 4692–4695. 57 indexed citations

14.

Eary, C. Todd, Robert D. Groneberg, Laurence E. Burgess, et al.. (2007). Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2608–2613. 74 indexed citations

15.

Allen, Shelley, Benjamin P. Fauber, Aaron S. Anderson, et al.. (2004). Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(22). 5537–5542. 30 indexed citations

16.

Pauly, Thomas, Traian Sulea, Mark Ammirati, et al.. (2003). Specificity Determinants of Human Cathepsin S Revealed by Crystal Structures of Complexes^,. Biochemistry. 42(11). 3203–3213. 70 indexed citations

17.

Robinson, Ralph P., Ellen R. Laird, Kathleen M. Donahue, et al.. (2001). Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(9). 1211–1213. 18 indexed citations

18.

Robinson, Ralph P., Ellen R. Laird, James F. Blake, et al.. (2000). Structure-Based Design and Synthesis of a Potent Matrix Metalloproteinase-13 Inhibitor Based on a Pyrrolidinone Scaffold. Journal of Medicinal Chemistry. 43(12). 2293–2296. 30 indexed citations

19.

Reiter, Lawrence A., James P. Rizzi, Jayvardhan Pandit, et al.. (1999). Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket. Bioorganic & Medicinal Chemistry Letters. 9(2). 127–132. 31 indexed citations

20.

Hatada, Marcos, Xiaode Lu, Ellen R. Laird, et al.. (1995). Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature. 377(6544). 32–38. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact